Blog

8 Articles

Aqua gloved hands holding lab equipment
Research
January 2, 2024 • 5 Min

Progress and Promise—Research in 2023

What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?

Dr. Tanios Bekaii-Saab
Research
December 16, 2022 • 4 Min

NAPOLI-3 Trial Meets Primary Endpoint in Metastatic Disease

Dr. Tanios Bekaii-Saab explains the early positive results from the NAPOLI-3 clinical trial, testing the NALIRIFOX combination.

Shawnee Daniels Sykes
Survivor Stories
August 4, 2022 • 4 Min

A Changing Treatment Plan

Shawnee Daniels-Sykes and her doctors have been changing her treatment plan to match her stage IV pancreatic cancer.

DNA helix made of metal, plastic and stained glass
Research
January 10, 2020 • 2 Min

Drug Combination to Combat Pancreatic and other Gastrointestinal Cancers

Researchers are testing a drug combination of TAS-102, an approved drug for colorectal cancer, and nanoliposomal irinotecan, on gastrointestinal cancers.

A latex-gloved hand doing close lab work
Research
March 5, 2019 • 2 Min

Targeting Cancer-Associated Wasting With Experimental Immunotherapy

Wasting, or cachexia, is the focus of a clinical trial testing a cachexia immunotherapy treatment combined with standard pancreatic cancer treatment.

Pancreas cross section embedded in paraffin wax, stained blue and purple, 100x magnification.
Research
January 16, 2017 • 2 Min

Comparing a Standard Chemotherapy With and Without a PARP Inhibitor

A clinical trial compares standard chemotherapy with and without the addition of a PARP inihibitor, for patients whose pancreatic cancer is spreading again.

Four transparent oblong orange pills and five round white pills on an orange background
Research
October 31, 2016 • 2 Min

Using a Vitamin to Make Low-Dose Chemotherapy More Effective

A clinical trial compares the effectiveness of low-dose continuous chemotherapy with and without high doses of vitamin C.

lab cylinders, beakers, glass bottles upside down on a drying rack
Research
April 17, 2016 • 3 Min

Drug Onivyde Gives New Hope to Patients with Advanced Pancreatic Cancer

Onivyde (injectable irinotecan), combined with fluorouracil and leucovorin, has been approved as a second-line treatment for advanced pancreatic cancer.